Product information and disease descriptionPlace of product in therapyDisease description
Clinical presentation - signs and symptoms
21 evidence topics · 15 sources
Gastrointestinal symptoms: intestinal attacks
Airway symptoms: obstruction risk
Distribution of attacks by site: edema episodes reported by 221 patients
“Skin swellings, including extremity, facial, genital, and trunk swellings, and abdominal attacks occurred in 97.4% of all edema episodes of the disease.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The other episodes were laryngeal edema (0.9%); edema of the soft palate (0.6%); tongue swellings (0.3%); headache episodes (0.7%); episodes affecting urinary bladder (0.3%), chest (0.2%), muscles (0.4%), joints (0.1%), kidneys (0.1%), and esophagus (0.05%), and were partly combined with other edema episodes.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Abdominal and laryngeal involvement: proportion of patients affected
“Abdominal involvement occurs in 70%–90% of all individuals and is associated with high morbidity.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Laryngeal involvement, although accounting for less than 1% of all attacks, poses a risk of death and occurs at least once in about half of patients.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Airway symptoms: phases of fatal laryngeal attacks
“Phase 1, the predyspnea phase, lasted on average for 3.7 ± 3.2 hours (range, 0-11 hours).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Phase 2, the dyspnea phase, lasted on average for 41 ± 49 minutes (range, 2 minutes to 4 hours).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Prodromal symptoms and erythema marginatum
“Non-specific prodromal symptoms are common and can include anxiety, nausea, paresthesia, and fatigue.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“One third of patients with HAE, especially children, experience erythema marginatum (a nonpruritic form of flat, figurate erythema) as an initial manifestation, which may mimic the skin lesions of urticaria.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Abdominal symptoms: presentation resembling an acute surgical abdomen
“Abdominal attacks can cause severe abdominal pain, nausea, and vomiting and may lead to unnecessary abdominal surgery, as the clinical presentation can resemble an acute surgical abdomen.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In some cases, intestinal angioedema may be accompanied by ascites and, very rarely, by hypovolemic shock.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Laryngeal symptoms: frequency, age at first episode, and time to maximum swelling in 123 patients
“Information on 123 patients with hereditary angioedema was obtained from medical histories and reports by the general practitioners, emergency physicians, and hospitals involved.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Sixty-one patients (49.6%) experienced a total of 596 laryngeal edema episodes.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The ratio of laryngeal edema episodes to skin swellings and abdominal pain attacks was approximately 1:70:54 in patients who had laryngeal edema.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The mean (SD) age at the first laryngeal edema was 26.2 (15.3) years.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The mean interval between onset and maximum development of laryngeal edema was 8.3 hours.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“In adults, the interval between onset of symptoms and acute risk of asphyxiation is usually long enough to allow for use of appropriate emergency procedures.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Laryngeal symptoms: facial edema as a risk factor
Laryngeal attacks during long-term prophylaxis: systematic review
“Attacks at all anatomic locations, including laryngeal attacks, continued to occur in patients who received LTP, regardless of the LTP agent” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Of note, both interventional and observational studies reported that laryngeal attacks accounted for between 2%-7% of all attacks in patients who received LTP with pdC1INH, lanadelumab, danazol, or TA” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Prodromal symptoms: frequency, specificity, and sensitivity for predicting an attack
“Prodromal symptoms, traditionally reported in up to 65%–70% of attacks, present an opportunity for early intervention but may lead to overuse of ODT.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Recent studies indicate that although the specificity of prodromal symptoms for an attack exceeds 95%, their sensitivity for accurately predicting an attack varies from 18% to 64%, depending on the attack site.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Prodromal symptoms: prospective study of 48 patients
“In the present study, a cohort of 48 HAE patients prospectively reported four events of prodromes followed by attack, attacks not preceded by a prodrome and incidents with only a prodrome.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We received reports on 119 prodromes and 192 attacks.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The majority experienced a prodrome before at least one of their attacks, and 64% affirmed that they can predict an oncoming attack by having a prodrome.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Mean duration of prodromes was significantly shorter than attacks, and prodromes overlapped the attack in 24.3% of cases.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Sensitivity of the prodrome as a predictor of attack was 95% to 99%, and specificity 18% to 64%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Pain and swelling during attacks: European patient survey of 186 patients
“The HAE Burden of Illness Study in Europe was conducted in Spain, Germany, and Denmark to assess the real-world experience of HAE from the patient perspective via a one-time survey, which included items on clinical characteristics and physical and emotional impacts.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“One hundred eighty-six patients participated; 59% reported having an attack at least once a month, 67% reported moderate-to-severe pain during their last attack, and 74% reported moderate-to-severe swelling.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The most common sites of the last attack were the abdomen and extremities; 24% experienced an attack in more than one site.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Psychological symptoms during attacks: anxiety in the KONFIDENT trial
“Participants in the randomised, double‐blind, phase 3 KONFIDENT trial (NCT05259917) treated attacks with sebetralstat 300 mg, 600 mg or placebo as early as possible after onset.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Overall, 115 (44%) attacks were rated as inducing moderate‐to‐extreme anxiety.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Female sex, shorter time since HAE diagnosis and greater attack severity were associated with greater anxiety at treatment administration.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Attack site, severity, and duration with and without on-demand treatment: Milan cohort of 227 patients
“From January 2009 to August 2014, data on attacks and treatments were collected from 227 patients from our centre in Milan.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 4244 attacks were reported; 50% were treated with approved therapies (pdC1-INH or icatibant), 15% were with tranexamic acid, and 35% were not treated.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Attack locations were peripheral cutaneous (46%), abdominal (34%), multiple (12%), facial (5%) and laryngeal (3%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Attack severities were moderate (48%), mild (28%) and severe (24%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Median attack duration (data available for 2393 attacks) with approved therapies was 10 h, significantly shorter than without treatment (45 h) or with tranexamic acid (38 h).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Attack site and duration with and without on-demand treatment: Milan angioedema centre, 2014
“This is a prospective observational study conducted at Milan angioedema centre between 1 January and 31 December 2014.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Overall, 133 of 167 patients (79.6%) reported 1508 attacks during the study period, with mean incidence of 11 attacks per patient per year.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Attacks were more often peripheral (47.6%), followed by abdominal attacks (39.4%), facial attacks (6.2%) and laryngeal attacks (4.8%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Both icatibant and pdC1-INH significantly reduced attack duration compared with no treatment (median times from onset 7, 10 and 47 hours, respectively)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In addition, shorter time to treatment was associated with a small (2%) but significant positive effect on remission rates (HR 0.98, 95% CI 0.97 to 0.99), suggesting that each additional hour between onset of symptoms and treatment administration would increase the chance of a faster resolution by approximately 2%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Attack progression with delayed or no treatment: US patient survey
“Patients with HAE (type I or II) aged 12 years or older with more than or equal to 1 treated (Treated Cohort) or untreated (Untreated Cohort) attack in the past 3 months were recruited by the US HAE Association.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Time to treatment paralleled changes in attack severity (33% mild attacks treated in <1 hour vs 67% in ≥1 hour, progressed to moderate/severe) and mean duration (<1 hour: 0.7 day; >8 hours: 2.7 days).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“In the Untreated Cohort (n = 20), 50% of the respondents describing their last untreated attack as mild experienced progression to moderate or severe and 25% reported spread to another site including the larynx and face.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Untreated attacks lasted a mean of 2.3 days.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Attack severity mix at treatment in placebo-controlled trials of an oral on-demand treatment
“Sebetralstat, an oral plasma kallikrein inhibitor, was evaluated in 2 randomized, placebo-controlled clinical trials, which instructed early treatment of attacks with no minimum severity requirement.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“377 attacks were treated: 87 with sebetralstat 300 mg; 151 with sebetralstat 600 mg; 139 with placebo.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Baseline severity was rated as "Mild" (46.2%), "Moderate" (40.6%), or "Severe"/"Very Severe" (12.7%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“At the time of attack onset, 156 attacks (41.4%) were mucosal; of these, 115 (30.5%) were abdominal-only attacks, and 8 (2.1%) were laryngeal attacks.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For sebetralstat 300 mg, sebetralstat 600 mg, and placebo, earlier-treated attacks (43.5%, 55.6%, and 48.0%, respectively) were more likely to be mild compared with later-treated attacks (29.6%, 33.3%, and 31.3%, respectively)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Presentation of HAE with normal C1-INH
“The clinical manifestations of HAE-nC1-INH are similar to those of HAE-C1-INH, and the 2 are largely indistinguishable based on signs and symptoms alone.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“However, in certain HAE-nC1-INH subtypes, angioedema attacks tend to have a later onset and may be accompanied by local hematomas.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote